Research and experimental development on natural sciences and engineering
VIDUNDERLIG PHARMACEUTICALS AS
Revenue 2024
NOK 0
Operating profit
NOK 0
Equity
NOK 0
Incorporated
2022
Share capital
NOK 30,000
Register information
- Legal form
- Limited company (AS)
- Industry
- Research and experimental development on natural sciences and engineering (72.100)
- Sector
- Private non-financial incorporated enterprises
- Incorporated
- 20 Aug 2022
- Registered
- 2 Sep 2022
- Municipality
- OSLO
- County
- Oslo
- Latest accounts
- 2024
Contact
- Address
- Falbes gate 18A, 0170 OSLO
Registers
MVA-registretNei
ForetaksregisteretJa
StiftelsesregisteretNei
FrivillighetsregisteretNei
Share capital
- Type
- Aksjekapital
- Amount
- NOK 30,000 NOK
- Number of shares
- 1000
- Registered
- 2 Sep 2022
Purpose and activity
- Articles of association
- 2022-08-20
- Purpose
- Utvikling av antistoff-legemiddel konjugat (ADC)- medisin mot HER2(reseptor tyrosine-protein kinase erbB-2), receptor tyrosine-protein kinase erbB-3(HER3) og Tumor-associated calcium signal transducer 2(TROP-2/TACSTD2) positiv brystkreft samt ADC-medisin mot myelomatose og mantle cell lymphom.
- Activity
- Utvikling av antistoff-legemiddel konjugat (ADC)- medisin mot HER2(reseptor tyrosine-protein kinase erbB-2), receptor tyrosine-protein kinase erbB-3(HER3) og Tumor-associated calcium signal transducer 2(TROP-2/TACSTD2) positiv brystkreft samt ADC-medisin mot myelomatose og mantle cell lymphom.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.